Remus Pharmaceuticals Ltd IPO: Issue Details, Open/Close Date | Research 360 by Motilal Oswal
Back arrow

Remus Pharma.

CMP

2,200.00

-74.45 (-3.27%)

  • DRHP
₹1,229

Offer Price

₹ 47.69 Cr

Issue Size

₹ 1,22,900

Min Investment

100

Lot size

Time Line

  • 17
    May 2023
    Open
  • 19
    May 2023
    Close
  • 24
    May 2023
    Finalisation of Basis of Allotment
  • 25
    May 2023
    Initiation of Refunds
  • 26
    May 2023
    Transfer of Shares to Demat Account
  • 29
    May 2023
    Listing Date

Risks

  • There are outstanding legal proceedings involving the Company, its Directors and the company Promoter.

  • The Company is dependent on few numbers of customers for sales. Loss of any of this large customer may affect its revenues and profitability.

  • The Company is dependent on few suppliers for purchase of product. Loss of any of these large suppliers may affect its business operations.

  • The company registered office, corporate office and warehouse, from where we operate are not owned by it.

  • The company relies on third parties for manufacturing products of the Company.

Financials

Revenue
18.42
24.72
45.03
Gross Profit
11.89
4.82
1.58
Net Income
8.50
3.43
1.06
Mar-2021Mar-2021Mar-2022Mar-2022Mar-2023Mar-2023

All values in Cr

Mar-2021 Mar-2022 Mar-2023 3-Yr trend
Revenue 18.42 (54.50%) 24.72 (34.20%) 45.03 (82.20%)
Gross Profit 1.58 (31.70%) 4.82 (205.10%) 11.89 (146.70%)
Net Income 1.06 (30.90%) 3.43 (223.60%) 8.50 (147.80%)
Assets 3.42 (39.00%) 6.77 (98.00%) 27.35 (304.00%)
Liabilities 0.28 (-36.40%) 0.19 (-32.10%) 8.21 (4,221.10%)

Book Running Managers

  • Beeline Capital Advisors Pvt Ltd

Registrar & Transfer Agent

MUFG Intime India Pvt Ltd

C-101 247 Park,
L B S Marg,
Vikhroli West - Mumbai-400083
Phone : 91-22-49186000 Fax: 91-22-49186060

Company Contact Information

1101 to 1103 South Tower One42,
B/H Ashok Vatika Amblibopal Rd,
Ahmedabad - 380054
Phone : 91-079-29999857 Email : cs@remuspharma.com https://www.remuspharma.com

Offer Related Information

Initial public issue of 388000 equity shares of face value of Rs. 10/- each of Remus Pharmaceuticals Limited ("RPL" or the "Company" or the "Issuer") for cash at a price of Rs. 1229/- per equity share including a share premium of Rs. 1219/- per equity share (the "Issue Price") aggregating to Rs. 47.69 crores ("The Issue"), of which 19500 equity shares of face value of Rs. 10/- each for cash at a price of Rs. 1229/- per equity share including a share premium of Rs. 1219/- per equity share... More

Remus Pharma. FAQ's

The shares of Remus Pharma. were first listed on the stock exchanges on June 26, 2024.

The total issue size of the Remus Pharma. IPO was 1,10,00,000 shares, amounting to Rs. 132 crore. they

The minimum lot size for Remus Pharma. public issue was 125 shares.

The price band of the IPO of Remus Pharma. was Rs. 114 to Rs. 120 per equity share.

Remus Pharma. IPO is a public issue through which the company raised approximately Rs. 132 crore by issuing around 1.1 crore equity shares to the public. After a successful IPO, the company’s shares are currently listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE), where they are freely traded without restrictions.

Bigshare Services Private Limited is the registrar and share transfer agent of Remus Pharma. IPO.

qr-code
login-icon

Take your research to the next level.
Login now to unlock Exclusive Features!

login-icon-1

Take your research to the next level.
Login now to unlock Exclusive Features!

Download Our App On:

SunMonTueWedThuFriSat
2627282930311234567891011121314151617181920212223242526272829303112345